NCT06617767
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Yüce Osmaniye, Turkey (Türkiye)
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,679 public trials
158 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT05577728
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
NCT03817463
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Steno Diabetes Center Copenhagen, Department of Clinical Epidemiology Gentofte Municipality, Denmark
- Helsinki University Hospital Helsinki, Finland
- University of Ulm, Institute for Epidemiology and medical biometry Ulm, Germany
- Maccabi Healthcare Services Tel Aviv, Israel
NCT05465317
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Duke Clinical Research Institute Durham, North Carolina, United States
NCT04537624
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Master Centre Switzerland Zurich, Oerlikon, Switzerland
NCT06586775
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- Dr.keerthana Rohtak, Haryana, India
Completed
A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes
NCT04109547
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Bouzareah Diabetic House Algiers Algeria Algiers, Algeria
- UH of Douera Algiers, Algeria
- The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
- Beijing Pinggu Hospital Beijing, Beijing Municipality, China
Completed
Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes
NCT04017221
- Conditions
- Acid-Base Imbalance, Acidosis, Diabetes Complications, +10 more
- Locations
-
- Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada
Completed
A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India
NCT05502562
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
Not specified
NCT05542420
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novo Nordisk Investigational Site Bengaluru, India
- Novo Nordisk Investigational Site Karachi, Pakistan
- Novo Nordisk Investigational Site Bangkok, Thailand